You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

INDOMETHACIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Indomethacin Sodium, and what generic alternatives are available?

Indomethacin Sodium is a drug marketed by Hospira, Navinta Llc, and West-ward Pharms Int. and is included in three NDAs.

The generic ingredient in INDOMETHACIN SODIUM is indomethacin sodium. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indomethacin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Indomethacin Sodium

A generic version of INDOMETHACIN SODIUM was approved as indomethacin sodium by WEST-WARD PHARMS INT on July 16th, 2008.

  Try a Trial

Drug patent expirations by year for INDOMETHACIN SODIUM
Recent Clinical Trials for INDOMETHACIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ciusss de L'Est de l'Île de MontréalN/A
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all INDOMETHACIN SODIUM clinical trials

Pharmacology for INDOMETHACIN SODIUM

US Patents and Regulatory Information for INDOMETHACIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira INDOMETHACIN SODIUM indomethacin sodium INJECTABLE;INJECTION 204118-001 Apr 19, 2016 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Navinta Llc INDOMETHACIN SODIUM indomethacin sodium INJECTABLE;INJECTION 206561-001 Jul 19, 2017 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West-ward Pharms Int INDOMETHACIN SODIUM indomethacin sodium INJECTABLE;INJECTION 078713-001 Jul 16, 2008 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.